Stifel Nicolaus Cuts Kits Eyecare (TSE:KITS) Price Target to C$21.00

Kits Eyecare (TSE:KITS) had its price target decreased by Stifel Nicolaus from C$24.00 to C$21.00 in a report issued on Thursday,BayStreet.CA reports. The firm presently has a “buy” rating on the stock. Stifel Nicolaus’ price objective indicates a potential upside of 83.73% from the stock’s previous close.

Several other research analysts have also recently commented on KITS. ATB Cormark Capital Markets reduced their target price on shares of Kits Eyecare from C$20.00 to C$16.75 and set a “speculative buy” rating for the company in a report on Thursday. Desjardins lowered their price target on shares of Kits Eyecare from C$25.00 to C$23.00 and set a “buy” rating on the stock in a research note on Thursday. Four equities research analysts have rated the stock with a Buy rating, According to MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of C$20.69.

Kits Eyecare Stock Performance

TSE KITS traded down C$0.95 during trading on Thursday, hitting C$11.43. The stock had a trading volume of 306,356 shares, compared to its average volume of 115,911. Kits Eyecare has a 12 month low of C$11.12 and a 12 month high of C$22.56. The stock has a market capitalization of C$388.51 million, a price-to-earnings ratio of 127.00 and a beta of 0.46.

Kits Eyecare (TSE:KITS) last issued its quarterly earnings results on Wednesday, May 6th. The company reported C$0.06 earnings per share for the quarter. The business had revenue of C$57.47 million for the quarter.

About Kits Eyecare

KITS (TSX: KITS) is one of the world’s fastest growing eyecare providers, offering high-quality, affordable prescription glasses and contact lenses through its vertically integrated digital platform. With advanced in-house lens manufacturing, an industry-leading digital fit experience powered by OpticianAI, and thousands of 5-star customer reviews, KITS is redefining how Canadians experience eyecare. Designed in Canada. Delivered worldwide.